Breaking News Instant updates and real-time market news.

FOLD

Amicus

$13.28

-0.39 (-2.85%)

07:11
09/13/17
09/13
07:11
09/13/17
07:11

Technical View: Amicus drops after Phase 3 SD-101 study results

The stock was last down over 5.9% in pre-market trading to $12.49. At that price next support is at $11.94. Resistance is at the $13 area.

  • 13

    Sep

FOLD Amicus
$13.28

-0.39 (-2.85%)

06/05/17
JPMS
06/05/17
NO CHANGE
Target $13
JPMS
Overweight
Amicus shares can double on positive zorblisa data, says JPMorgan
JPMorgan analyst Anupam Rama believes investor sentiment remains very low on Amicus Therapeutics' Phase 3 readout of zorblisa. The Phase 3 Essence data for the treatment of epidermolysis bullosa are expected in Q3. The trial is "high-risk/high-reward," Rama tells investors in a research note. The analyst says he's taking a "very conservative" approach for zorblisa with $300M in peak sales and a 40% probability of success. Rama believes the stock at current levels reflects no value for zorblisa. On positive data, Amicus shares have the potential to double, Rama writes. On negative data, he sees only "sentiment based" downside of 5%-15%. The analyst keeps an Overweight rating on Amicus with a $13 price target.
07/11/17
JPMS
07/11/17
NO CHANGE
JPMS
Overweight
Amicus could be up 15%-20% on today's news, says JPMorgan
JPMorgan analyst Anupam Rama believes shares of Amicus Therapeutics could be up 15%-20% today on news of the FDA confirming that the regulatory filing for migalastat for the treatment of Fabry can now be submitted. The stock in premarket trading is up 31% to $13.45. The analyst estimates that a U.S. launch of migalastat is now moved up by two years. Rama has an Overweight rating on Amicus.
07/11/17
COWN
07/11/17
NO CHANGE
Target $16
COWN
Outperform
Amicus price target raised to $16 from $10 at Cowen
08/17/17
JPMS
08/17/17
NO CHANGE
JPMS
JPMorgan lists top SMID Biotechnology picks following Q2 results
Analysts at JPMorgan continue think selectively remains important in the small-to-mid cap Biotechnology space. The analysts listed their favorite ideas in "five key buckets." Amicus (FOLD) is the top long-term pick, Ironwood (IRWD) is the top pick among relative underperformers, Otonomy (OTIC) is the top play for a clinical/binary event, Sarepta (SRPT) is the name to take advantage of the recent share weakness, and Ignyta (RXDX) is the "underfollowed/undervalued" favorite, according to JPMorgan's Biotech team.

TODAY'S FREE FLY STORIES

VMW

VMware

$132.75

0.61 (0.46%)

10:02
01/17/18
01/17
10:02
01/17/18
10:02
Conference/Events
VMware management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 19

    Jan

GS

Goldman Sachs

$252.90

-5.33 (-2.06%)

10:01
01/17/18
01/17
10:01
01/17/18
10:01
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs CFO:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

BAH

Booz Allen

$40.02

0.16 (0.40%)

10:01
01/17/18
01/17
10:01
01/17/18
10:01
Hot Stocks
Booz Allen awarded $165M 5-year contract to support USCYBERCOM »

the General Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CMTL

Comtech

$21.40

-0.58 (-2.64%)

10:01
01/17/18
01/17
10:01
01/17/18
10:01
Hot Stocks
Comtech receives $19.1M follow-on contract »

Comtech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:01
01/17/18
01/17
10:01
01/17/18
10:01
General news
Housing Market Index data reported »

January Housing Market…

ACLS

Axcelis

$30.30

1.15 (3.95%)

, AMAT

Applied Materials

$54.50

1.05 (1.96%)

10:00
01/17/18
01/17
10:00
01/17/18
10:00
Recommendations
Axcelis, Applied Materials analyst commentary  »

Axcelis lowered margin…

ACLS

Axcelis

$30.30

1.15 (3.95%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

FAST

Fastenal

$55.44

-0.15 (-0.27%)

10:00
01/17/18
01/17
10:00
01/17/18
10:00
Options
Fast action in Fastenal Feb 55s post earnings »

Fast action in Fastenal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

GS

Goldman Sachs

$253.61

-4.855 (-1.88%)

10:00
01/17/18
01/17
10:00
01/17/18
10:00
Hot Stocks
Goldman CFO: Trading facing 'low volatility, low activity' world »

CFO Marty Chavez said on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

MVC

MVC Capital

$10.70

-0.02 (-0.19%)

09:59
01/17/18
01/17
09:59
01/17/18
09:59
Conference/Events
MVC Capital management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

KEYW

KEYW

$6.46

0.09 (1.41%)

09:58
01/17/18
01/17
09:58
01/17/18
09:58
Conference/Events
KEYW management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 21

    Feb

  • 22

    Feb

  • 14

    Jun

RIOT

Riot Blockchain

$18.28

-3.6 (-16.45%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Options
Riot Blockchain Inc put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

LRCX

Lam Research

$190.39

1.88 (1.00%)

, MNST

Monster Beverage

$64.56

0.79 (1.24%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Options
Early notable gainers among liquid option names on January 17th »

Notable gainers among…

LRCX

Lam Research

$190.39

1.88 (1.00%)

MNST

Monster Beverage

$64.56

0.79 (1.24%)

IBM

IBM

$167.92

4.07 (2.48%)

IFF

International Flavors

$155.52

2.98 (1.95%)

KLAC

KLA-Tencor

$107.66

0.37 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

DIS

Disney

$110.92

0.23 (0.21%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Periodicals
Disney's 'Last Jedi' drops 92% in second weekend at Chinese box office, THR says »

Disney's "Star…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 06

    Feb

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

, HD

Home Depot

$197.20

0.89 (0.45%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Conference/Events
Wedbush retail/hardlines analyst holds an analyst/industry conference call »

Retail/Hardlines Analyst…

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

HD

Home Depot

$197.20

0.89 (0.45%)

LOW

Lowe's

$101.01

0.0371 (0.04%)

W

Wayfair

$84.68

0.18 (0.21%)

WSM

Williams-Sonoma

$54.02

0.17 (0.32%)

BBBY

Bed Bath & Beyond

$23.01

0.19 (0.83%)

TPX

Tempur Sealy

$63.72

-0.075 (-0.12%)

AZO

AutoZone

$780.00

-1.02 (-0.13%)

AAP

Advance Auto Parts

$114.60

0.703 (0.62%)

ORLY

O'Reilly Automotive

$257.89

-0.71 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 08

    Feb

  • 18

    Feb

  • 20

    Feb

  • 22

    Feb

  • 18

    Mar

MRK

Merck

$62.32

0.25 (0.40%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Conference/Events
Leerink pharmaceuticals analysts hold an analyst/industry conference call »

Analysts discuss whether…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

FB

Facebook

$178.39

-0.98 (-0.55%)

, TWTR

Twitter

$24.52

-0.14 (-0.57%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Committee holds a…

FB

Facebook

$178.39

-0.98 (-0.55%)

TWTR

Twitter

$24.52

-0.14 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

OPGN

OpGen

$0.19

0.0143 (8.29%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Conference/Events
OpGen to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

09:54
01/17/18
01/17
09:54
01/17/18
09:54
General news
Market opens with gains, but holding them will be the focus »

Stock futures were higher…

ACLS

Axcelis

$30.30

1.15 (3.95%)

09:53
01/17/18
01/17
09:53
01/17/18
09:53
Hot Stocks
Breaking Hot Stocks news story on Axcelis »

Axcelis drops 5% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

XLF

Financial Select Sector

$29.16

0.01 (0.03%)

, XLE

Energy Select Sector SPDR

$76.69

0.25 (0.33%)

09:52
01/17/18
01/17
09:52
01/17/18
09:52
Technical Analysis
Technical Take: S&P 500 moves moderately higher, sector breadth mixed »

The S&P 500 (SPX) was…

XLF

Financial Select Sector

$29.16

0.01 (0.03%)

XLE

Energy Select Sector SPDR

$76.69

0.25 (0.33%)

XLI

Industrial Select Sector SPDR

$79.59

0.14 (0.18%)

XLK

Technology Select Sector SPDR

$66.91

0.36 (0.54%)

XLP

Consumer Staples Sector SPDR

$57.23

0.32 (0.56%)

XLV

Health Care Select Sector SPDR

$87.53

0.28 (0.32%)

SPY

SPDR S&P 500 ETF Trust

$277.86

0.89 (0.32%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QADB

QAD Inc

$31.80

0.05 (0.16%)

09:50
01/17/18
01/17
09:50
01/17/18
09:50
Hot Stocks
Breaking Hot Stocks news story on QAD Inc 

QAD Inc trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITIC

Investors Title Company

$199.00

3.26 (1.67%)

09:50
01/17/18
01/17
09:50
01/17/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Investors Title Company »

Investors Title Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$57.07

0.16 (0.28%)

09:45
01/17/18
01/17
09:45
01/17/18
09:45
Technical Analysis
Technical Take: Consumer Staples Sector SPDR nearing breakout »

The Consumer Staples…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QADB

QAD Inc

$31.80

0.05 (0.16%)

09:45
01/17/18
01/17
09:45
01/17/18
09:45
Hot Stocks
Breaking Hot Stocks news story on QAD Inc »

QAD Inc trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITIC

Investors Title Company

$199.00

3.26 (1.67%)

09:45
01/17/18
01/17
09:45
01/17/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Investors Title Company »

Investors Title Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.